September 10, 2009

Takeda Pharmaceutical Company Limited
IBM Japan, Ltd.
Cisco Systems G.K.

Takeda Introduces ‘Cisco TelePresence’ (Advanced Videoconferencing System)

Osaka, Japan, September 10, 2009 --- Takeda Pharmaceutical Company Limited (Head Office: Chuo-ku, Osaka; President: Yasuchika Hasegawa, “Takeda”) announced today that it has introduced Cisco TelePresence™, －an advanced videoconferencing system providing both high-resolution visuals and a high-quality audio environment. Cisco TelePresence™ was provided by Cisco Systems G.K. (Headquarters: Minato-ku, Tokyo; President & CEO: Edzard J.C. Overbeek, “Cisco”), and IBM Japan, Ltd. (Headquarters: Minato-ku, Tokyo; President: Takayuki Hashimoto; NYSE: IBM, “IBM Japan”) provided support to introduce this videoconfereincing system at Takeda. .

The Cisco TelePresence™ system now connects Takeda’s Tokyo Head Office, Takeda Pharmaceuticals North America Inc.^[*] (IL, U.S.A., “TPNA”), and Millennium: The Takeda Oncology Company^[*] (MA, U.S.A., “Millennium”). Takeda is planning to install this system at more of its business sites across the globe, with the next sites being its Head Office in Osaka and Takeda Pharmaceuticals Europe, Inc. (London, U.K., “TPEU”)^[*], where introduction is scheduled by the end of this year.

[*] Wholly-owned subsidiaries of Takeda

Unlike conventional videoconferencing equipment, Cisco TelePresence™ offers unique design configurations such as continuous presence, meaning that the tables and backgrounds in other parties’ conference rooms appear on the screen as if they were part of one’s own conference room. Additionally, life-size projections enable communication with other parties as if they were sitting face-to-face at the same table. Cisco and IBM Japan believe that Cisco TelePresence™ is a powerful tool to support cross-cultural communication, which requires speakers to interpret not only the words, but also the subtle messages conveyed by facial expressions and body language.

By utilizing Cisco TelePresence™ solutions, Takeda expects to have more frequent and fluent communication with its various global subsidiaries, thereby further enhancing the quality and speed of its decision-making, while at the same time allowing for savings in time and money related to business travel.

<About Takeda>

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Takeda is enhancing its R&D pipeline by concentrating its management resources in the following selected core therapeutic areas: “lifestyle-related diseases,” “oncology and urological diseases (including gynecology),” “central nervous system diseases (including bone and joint disorders,” and “gastroenterological diseases.” For more information, please visit http://www.takeda.com/.

<About IBM>

Please visit .

<About Cisco Systems>

Cisco, (NASDAQ: CSCO), is the worldwide leader in networking that transforms how people connect, communicate and collaborate. Information about Cisco can be found at . For ongoing news, please go to .

For inquiries:

Takeda Pharmaceutical Company Limited, Corporate Communications Dept.: TEL 03-3278-2037
IBM Japan External Relations Kazuhiro Kaneko TEL:03-3808-4770 E-Mail:kazkjp.ibm.com
Cisco Systems G.K. Public Relations, Mari Okamoto  TEL： 03-6434-6500 E-Mail：press-jpcisco.com

###